Acquired Aplastic Anemia Market Exhibit a Considerable Growth at a CAGR of 7.6% Till 2023
Acquired Aplastic Anemia Market Key Players are Pfizer Inc. (U.S.), Bayer AG (Germany), Novo Nordisk AS (Dernmark), Shire (Republic of Ireland), SOBI (Sweden), Octapharma (Switzerland), CSL Limited (Australia), Amgen Inc., GlaxoSmithKline plc., and Bluebird bio.
View full press release